Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: ValuEngine, Inc.
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cerulean Pharma Inc announces closing of initial public offering

Tuesday, 15 Apr 2014 10:50am EDT 

Cerulean Pharma Inc:Closing of initial public offering of 8,500,000 shares of common stock at a public offering price of $7 per share, before underwriting discounts.Leerink Partners acted as sole book-running manager for the offering.Canaccord Genuity, JMP Securities and Wedbush PacGrow Life Sciences acted as co-managers for the offering. 

Company Quote

-0.09 -1.52%
29 May 2015